FDA.reportPublic FDA data

ACCURUN®

Primary DI
00816784020413
Brand
ACCURUN®
Company
Lgc Clinical Diagnostics, Inc.
Model
2015-0084
Catalog number
2015-0084
Device description
ACCURUN 140 Rubella IgG 1 x 5.0 mL
Published
2018-09-24
Public version status
Update
Distribution status
In Commercial Distribution
MRI safety
Labeling does not contain MRI Safety Information

Product Codes#

Code, Name table
CodeName
MJXKit, Serological, Positive Control

Product Code Classifications#

Code, Device, Specialty table
CodeDeviceSpecialtyClass
MJXKit, Serological, Positive ControlClinical Chemistry1

Premarket Submissions#

Submission, Supplement table
SubmissionSupplement
K972986000

Premarket Details#

Submission, Supplement, Device table
SubmissionSupplementDeviceApplicantDecision dateProduct code
K972986000ACCURUN 140 RUBELLA IGG POSITIVE CONTROLBoston Biomedica, Inc.1997-10-08MJX

Identifiers And Packaging#

Identifier, Type, Agency table
IdentifierTypeAgencyPackage quantityStatus
00816784020413PrimaryGS10

Alternate GTIN / UPC / EAN Codes

Source identifier, GTIN-14 normalized, UPC-A table
Source identifierGTIN-14 normalizedUPC-AEAN-13
00816784020413008167840204138167840204130816784020413

GMDN Terms#

Term, Definition table
TermDefinition
Rubella virus immunoglobulin G (IgG) antibody IVD, controlA material which is used to verify the performance of an assay intended to be used for the qualitative and/or quantitative detection of immunoglobulin G (IgG) antibodies to Rubella virus in a clinical specimen.

Storage And Handling#

Type, Low, High table
TypeLowHighCondition
Storage Environment Temperature2 Degrees Celsius8 Degrees Celsius

Sterilization Methods#

Method table
Method

Regulatory Flags#

DUNS number
106267123
Device count
1
Lot or batch
true
Expiration date on label
true

Other Devices From This Company#

Primary DI, Brand, Model table
Primary DIBrandModelCatalogPublished
00850011135891VALIDATE609re2026-06-02
00850011135860VALIDATE405re405re2026-04-29
00850011135747VALIDATE1004ro2026-04-24
00850075957330KOVA-Trol II Low Abnormal871302026-04-17
00850075957378KOVA-Trol III Normal with hCG873272026-04-17
00850075957385KOVA-Trol III Normal with hCG873312026-04-17
00850075957392KOVA-Trol I High Abnormal With Urobilinogen 873322026-04-17
00850075957408KOVA-Trol I High Abnormal With Urobilinogen 873342026-04-17
00850075957415KOVA-Trol III Normal with hCG875282026-04-17
00850075957439KOVA-Trol I High Abnormal with Urobilinogen Value Assignment875332026-04-17
00850075956319Optitrol NAT TriplexNT010422026-01-30
00850075956326Optitrol NAT TriplexNT010412026-01-30
00850075956999Optitrol HEPR-2SR120552026-01-30
00850075957002Optitrol HEPR-2SR120572026-01-30
00850075957033Optitrol Mumps MSR150652026-01-30
00850075957040Optitrol Mumps MSR150672026-01-30
00850075957057Optitrol Mumps MSR150682026-01-30
00850011135846VALIDATE807re2026-01-06
00850041090139ACCURUN EBV DNA Positive Control2020-02102025-11-21
00850041090146ACCURUN BKV DNA Positive Control 2020-02092025-11-21

Other Devices Sharing Product Codes#

Primary DI, Brand, Company table
Primary DIBrandCompanyProduct codePublished
15099590745172ACCESS HIV Ag/Ab combo QCBeckman Coulter, Inc.MJX2024-03-15
00840733103476RSV Positive ControlMERIDIAN BIOSCIENCE, INC.MJX2021-06-18
00380740131364AlinityAbbott GmbHMJX2020-11-06
10758750001149VITROSORTHO CLINICAL DIAGNOSTICSMJX2020-04-01
05055273216394SEROLOGY LYME DISEASE POSITIVE CONTROL (LYME CONTROL +)RANDOX LABORATORIES LIMITEDMJX2020-01-22
00380740011161ARCHITECTAbbott GmbHMJX2016-09-09
00380740011178ARCHITECTAbbott GmbHMJX2016-09-09
00380740011185ARCHITECTAbbott GmbHMJX2016-09-09